Get the Stockscreener App
47.09
1.10%
-0.488
Renaissance Ipo Etf stock is traded at $47.09, with a volume of 40,586.
It is down -1.10% in the last 24 hours and up +4.50% over the past month.
See More
Previous Close:
$47.58
Open:
$47.79
24h Volume:
40,586
Relative Volume:
1.08
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.29%
1M Performance:
+4.50%
6M Performance:
+29.06%
1Y Performance:
+33.27%
1-Day Range:
$47.04
$47.95
1-Week Range:
$45.15
$48.23
52-Week Range:
$34.06
$48.23
Renaissance Ipo Etf Stock (IPO) Company Profile
Name
Renaissance Ipo Etf
Sector
Industry
Phone
-
Address
-
Compare IPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPO
Renaissance Ipo Etf
|
47.16 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.37 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
601.45 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
604.40 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
247.66 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
523.96 | 124.43B | 0 | 0 | 0 | 0.00 |
Renaissance Ipo Etf Stock (IPO) Latest News
IPO NewsRenaissance Capital's January IPO Market Update - Renaissance Capital
IPO Roundup: Titan America, Aureus Greenway and more (IPO:NYSEARCA) - Seeking Alpha
US IPO Weekly Winners & Losers - Renaissance Capital
Maze Therapeutics stock hugs flat line following $140M IPO - MSN
Cloudastructure: CSAI IPO, TechnologyOffers AI-enabled video surveillance. - Renaissance Capital
10 Funds Hit Hardest by the DeepSeek AI Stock Downturn - Morningstar
Obesity drug developer Aardvark files for IPO - MSN
IPO Roundup: Smithfield Foods, Beta Bionics and more (NYSEARCA:IPO) - Seeking Alpha
Where are the Opportunities in (IPOS) - Stock Traders Daily
Objective long/short (IPO) Report - Stock Traders Daily
IPO Rebound In 2025? Here's What's Fueling The Boom, How ETFs Can Help Investors Capitalize - Benzinga
Obesity drug developer Aardvark files for IPO (IPO:NYSEARCA) - Seeking Alpha
A Bullish 2025 For The IPO Market? ETFs To Consider - Barchart
A Bullish 2025 for the IPO Market? ETFs to Consider - Yahoo Finance
IPO Roundup: Toppoint, Venture Global and more (NYSEARCA:IPO) - Seeking Alpha
SailPoint Parent files for $100M IPO - MSN
US IPO: Flowco Debuts, While More Sizable Deals Join The Pipeline - Seeking Alpha
Odyssey Therapeutics files for $100M IPO - MSN
US IPO Weekly Recap: Oil and gas well equipment provider Flowco debuts, while more sizable deals join the pipeline - Renaissance Capital
Renaissance IPO ETF (NYSEARCA:IPO) Stock Price Up 1% – Here’s Why - Defense World
(IPO) Proactive Strategies - Stock Traders Daily
Obesity drug developer Metsera files for $100M IPO - MSN
Obesity drug developer Metsera files for $100M IPO (IPO:NYSEARCA) - Seeking Alpha
IPO Roundup: Flowco Holdings, FBS Global and more (NYSEARCA:IPO) - Seeking Alpha
Aspargo Labs files to go public via direct offering - MSN
Nutraceuticals maker Functional Brands files for $6M IPO - MSN
U.S. IPO market’s $23.2 billion in year-to-date proceeds exceeds the $19.4 billion raised for all of 2023 - MSN
Diabetes device maker Beta Bionics files for $100M IPO (IPO:NYSEARCA) - Seeking Alpha
IPO Roundup: Cortigent, Diginex and more (NYSEARCA:IPO) - Seeking Alpha
Could These IPO Moves Redefine Your Strategy? Discover the Key Signals Now! - Jomfruland.net
(IPOS) Technical Data - Stock Traders Daily
When the Price of (IPO) Talks, People Listen - Stock Traders Daily
Renaissance Ipo Etf Stock (IPO) Financials Data
There is no financial data for Renaissance Ipo Etf (IPO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):